In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

The primaries are done. Runoffs are next. Stay informed with our Election 2026 newsletter. Never miss a story with The Brief, our free newsletter. Keep tabs on Texas politics and policy with our ...

In a letter dated December 9, and made public on December 10 according to Reuters, dozens of state and territorial attorneys general from all over the U.S. warned Big Tech that it needs to do a better ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

It was delightful to read a recent investigative report detailing Attorney General Aaron Ford’s busy travel schedule. Having worked alongside leadership figures in both public and private business ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

The FIND function allows you to find a text string within another. It returns the position at which a character or string begins within another text string. The output of the above function will be 5, ...

WASHINGTON (AP) — Defense Secretary Pete Hegseth has fired a general whose agency’s initial intelligence assessment of damage to Iranian nuclear sites from U.S. strikes angered President Donald Trump, ...